Ketamine and Propofol NeuroImaging
RecruitingEarly phase 1Healthy volunteers welcome
Who can join
Ages 18 to 59 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Adults 18-59 years of age, who: * have none of the specific exclusion criteria * have a valid email address and valid phone number throughout the study * free from any non-MRI compatible implants Exclusion Criteria: * are pregnant or attempting to conceive * body mass index (BMI) \> 35 * significant memory impairment or hearing loss * sleep apnea * chronic pain or frequently taking pain medication * chronic medical conditions requiring treatment (hypertension, diabetes, high cholesterol) * neurologic disease, including seizures and tremor * psychiatric diagnoses, including anxiety, depression, panic, or PTSD * a history of any of these medical conditions: abnormal heartbeats (cardiac conduction abnormality or arrhythmia), liver or kidney disease, or significant lung disease * severe claustrophobia or intolerance of an MRI * have metal implants or non-removable metal piercings * having a history of adverse reaction to ketamine or propofol * daily alcohol or heavy alcohol use; history of alcohol abuse * current daily smoker * regular or recent marijuana use (including prescribed/medical marijuana) * illicit drug use, i.e., street drugs * regularly taking: antiepileptics, antidepressants, anti-psychotics, antihistamines, anti-anxiety medication, stimulants, or sleep-aids
About the study
This is a multi-visit which will collect MRI (pictures of the brain) and EEG (brain waves) data to determine changes in brain connectivity and brain activity for memory formation and pain perception while receiving the commonly-used anesthetic agents ketamine and propofol, both alone and in combination.
What is being tested
- Propofol (drug)
- Ketamine (drug)
- Peripheral Nerve Stimulation (device)
Sponsor: Keith M Vogt · Participants: 60 · Started: Apr 10, 2026
Contact the study team
- Keith M Vogt, MD, PhD · Phone: 4126473147
Official record on ClinicalTrials.gov — NCT07294092
Locations in the U.S.
| Pennsylvania | University of Pittsburgh, Pittsburgh |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.